The influence of recombinant DNA-derived human and murine gamma interferons on mouse hepatic drug metabolism

Fundam Appl Toxicol. 1986 Jul;7(1):165-9. doi: 10.1016/0272-0590(86)90210-1.

Abstract

Human gamma interferon given for up to 5 days by subcutaneous infusion or intraperitoneal injection did not significantly alter mouse hepatic microsomal oxidative drug-metabolizing enzyme activities. In contrast, murine gamma interferon and human alpha interferon given for 5 days at the same dose (10(7) units/kg) caused 25 and 50% decreases, respectively, in hepatic microsomal cytochrome P-450 concentrations. The human alpha interferon-induced decline in cytochrome P-450 was accompanied by a significant drop in p-nitroanisole demethylase activity and significant elevations in serum alanine aminotransferase and cytosolic glutathione S-transferase activities. An elevation in glutathione-S-transferase was the only significant change found following human gamma interferon administration. Microsomal UDP-glucuronosyltransferase activity was unaffected by any interferon.

MeSH terms

  • Animals
  • Cytochrome P-450 Enzyme System / metabolism
  • Interferon-gamma / pharmacology*
  • Liver / drug effects
  • Liver / metabolism*
  • Male
  • Mice
  • Microsomes, Liver / drug effects
  • Microsomes, Liver / metabolism
  • Organ Size / drug effects
  • Pharmaceutical Preparations / metabolism*
  • Recombinant Proteins / pharmacology
  • Species Specificity
  • Time Factors

Substances

  • Pharmaceutical Preparations
  • Recombinant Proteins
  • Interferon-gamma
  • Cytochrome P-450 Enzyme System